Skip to main content
. 2018 Dec 6;10(4):263. doi: 10.3390/pharmaceutics10040263

Figure 2.

Figure 2

(a) The timeline of FDA-approved pharmaceutical products. (b) The number of marketed and discontinued new drugs. (c) The number of marketed and discontinued generic drugs. The blue columns represent marketed drugs and the grey columns represent discontinued drugs.